PedAM
Pediatric Disease Annotations & Medicines
| Disease | essential thrombocythemia |
| Symptom | C0040053|thrombosis |
| Sentences | 19 |
| PubMedID- 19582452 | Increased risk of recurrent thrombosis in patients with essential thrombocythemia carrying the homozygous jak2 v617f mutation. |
| PubMedID- 20623009 | This drug is often used to supplement phlebotomy for patients with polycythemia vera (pv; . |
| PubMedID- 25269924 | Acute myocardial infarction and sub-acute stent thrombosis associated with occult essential thrombocythemia. |
| PubMedID- 25872987 | New and treatment-relevant risk stratification for thrombosis in essential thrombocythemia and polycythemia vera. |
| PubMedID- 21062242 | Hemorrhage, thrombosis and leukemic transformation) of polycythemia vera (pv), essential thrombocythemia (et), and primary myelofibrosis (pmf), the advent of molecular biology has provided substantial molecular insight into the pathobiology of myeloproliferative neoplasia (mpn). |
| PubMedID- 25223529 | The importance of cardiovascular risk factors for thrombosis prediction in patients with essential thrombocythemia. |
| PubMedID- 23033268 | Accurate prediction of thrombosis in essential thrombocythemia (et) provides the platform for prospective studies exploring preventive measures. |
| PubMedID- 22446615 | We report a 13-year-old girl who presented with isolated cerebral venous thrombosis and was diagnosed with essential thrombocythemia. |
| PubMedID- 24709317 | Deep vein thrombosis occurs in 30% of patients with essential thrombocythemia, but rarely at initial diagnosis. |
| PubMedID- 24889737 | Mutations and thrombosis in essential thrombocythemia: prognostic interaction with age and thrombosis history. |
| PubMedID- 22781379 | Very late coronary drug-eluting stent thrombosis in a patient with essential thrombocythemia: a case report of a rare association. |
| PubMedID- 20483636 | The development of bone marrow fibrosis and thrombosis are main causes of morbidity in essential thrombocythemia (et). |
| PubMedID- 21287350 | Established risk factors for thrombosis in essential thrombocythemia (et) include age (>/= 60 years) and previous vascular events. |
| PubMedID- 25170413 | The risk of thrombosis is high in patients with essential thrombocythemia. |
| PubMedID- 21490340 | The current study clarifies the contribution of specific disease and host characteristics to the risk of arterial versus venous thrombosis in essential thrombocythemia. |
| PubMedID- 22537896 | Aortic thrombosis in a patient with essential thrombocythemia. |
| PubMedID- 24617727 | Decanucleotide insertion polymorphism of f7 significantly influences the risk of thrombosis in patients with essential thrombocythemia. |
| PubMedID- 25997869 | The impact of jak2v617f mutation on different types of thrombosis risk in patients with essential thrombocythemia: a meta-analysis. |
| PubMedID- 21142409 | Cerebral venous thrombosis due to essential thrombocythemia and worsened by heparin-induced thrombocytopenia and thrombosis. |
Page: 1